These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Development and manufacture of ophthalmic products. Mullins JD Bull Parenter Drug Assoc; 1966; 20(2):48-55. PubMed ID: 5905228 [No Abstract] [Full Text] [Related]
27. [Stability of aqueous solutions of aureomycin hydrochloride in the presence of some substances applied in ophthalmic drops]. Olszewski Z; Grabowska-Bochenek J Acta Pol Pharm; 1967; 24(5):505-9. PubMed ID: 6062758 [No Abstract] [Full Text] [Related]
28. [Prescriptions of ophthalmic solutions]. Pöppel P Pharm Prax; 1970; 2():31-5. PubMed ID: 5517092 [No Abstract] [Full Text] [Related]
29. [On problems in the preparation of ophthalmic solutions following DAB 7 with 2 or more drugs]. Brockelt G Pharm Prax; 1966; 6():135-7. PubMed ID: 5960337 [No Abstract] [Full Text] [Related]
30. Good manufacturing practice for single dose ophthalmic products. Hall NC Bull Parenter Drug Assoc; 1972; 26(4):193-7. PubMed ID: 5041145 [No Abstract] [Full Text] [Related]
31. [The influence of polivinyl chloride containers (PCW) on the quality of 5% glucose solution for injections. Part II (author's transl)]. Krasowska M Ann Univ Mariae Curie Sklodowska Med; 1976; 31():181-5. PubMed ID: 1032777 [No Abstract] [Full Text] [Related]
33. Elimination of particulate contamination from ophthalmic solutions for intraocular surgery. Jaffe NS Bull Parenter Drug Assoc; 1970; 24(5):218-25. PubMed ID: 5471332 [No Abstract] [Full Text] [Related]
34. A wide pH range stopper for improved particulate quality in parenteral solutions. Knapp JZ; Dull HF; Bjorndal PM; Brakl SF; Yuen PC J Parenter Sci Technol; 1984; 38(4):128-38. PubMed ID: 6491855 [No Abstract] [Full Text] [Related]
35. [Comments and control studies on the size of drug particles contained in ophthalmic ointments]. Doden W; Faulborn J Klin Monbl Augenheilkd; 1967; 150(5):727-32. PubMed ID: 5586134 [No Abstract] [Full Text] [Related]
36. Bacteriological control of collyria. Papavassiliou J; Albalas B; Zouroudis N; Chitiroglou-Lada K; Siouti M Pharm Acta Helv; 1977; 52(12):293-5. PubMed ID: 615315 [No Abstract] [Full Text] [Related]
37. Determinants of eye drop size. Van Santvliet L; Ludwig A Surv Ophthalmol; 2004; 49(2):197-213. PubMed ID: 14998692 [TBL] [Abstract][Full Text] [Related]
38. Preservative combinations: a microbiological assessment. Wakely JH; Hall NC; Krezanoski JZ Bull Parenter Drug Assoc; 1967; 21(4):124-35. PubMed ID: 6045458 [No Abstract] [Full Text] [Related]